Drug Type Monoclonal antibody |
Synonyms- |
Target |
Action inhibitors |
Mechanism Rh factor inhibitors(Blood group Rh(D) polypeptide inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Erythroblastosis, Fetal | Preclinical | Germany | 13 Oct 2025 | |
| Erythroblastosis, Fetal | Preclinical | India | 13 Oct 2025 | |
| Erythroblastosis, Fetal | Preclinical | Netherlands | 13 Oct 2025 |






